Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurexophilin and PC-esterase domain family member 2 pseudogene 1 (NXPE2P1) is classified as a pseudogene in humans and does not encode a functional protein[1][3][5][11]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they do not produce a functional product due to mutations or lack of regulatory elements. NXPE2P1 is not considered a drug target, biomarker, or molecule of therapeutic interest, and there is no evidence supporting a role in disease or biological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurexophilin and PC-esterase domain family member 2 pseudogene 1 (NXPE2P1).